Clinical trial
Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients…
NCT00145236 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00145236 |
|---|---|
| Title | Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension |
| Official title | A Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel Group Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension. |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Nebivolol |
| Enrollment | 300 |
| Start date | Nov 1, 2001 |
| Completion | Aug 1, 2003 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 14, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: